Public Procurement
On COVID-19 vaccines, contracts and innovation in public procurement
I have been considering writing or not about the current situation with the COVID-19 vaccines in the EU. First, the AstraZeneca row with the Commission and Member States and second, the difficulties in scaling up production. As for the first, now is not the moment to discuss the topic and